Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg vs. Placebo in Subjects With Lung Neuroendocrine Tumours
Clinical trial NCT02683941 · TERMINATED
Trial details
- NCT number
- NCT02683941
- Sponsor
- Ipsen
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-06
- Primary completion
- 2020-02-28
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.